Shinpoong Pharmaceutical is trading at 19,850 KRW as of 12:33 PM on the 22nd, down 0.5% from the previous day. This represents an 18.86% increase compared to April 29. Shinpoong Pharmaceutical is known as a pharmaceutical company focused on the sales of specialized therapeutic drugs.

Over the past five days, individual investors have net sold 59,115 shares, while foreigners and institutions have net bought 3,134 shares and 41,251 shares, respectively.

On May 19, Shinpoong Pharmaceutical became a market issue with the news, "President Trump taking malaria medication for COVID-19... Piramex Phase 2..."

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing